1: Wu Y, Xu M, Wang H, Xu X, Zhao S, Zhang M, Jin H, Yan J, Wang B, Gong J, Lu X, Peng J, Dai Q. Lercanidipine hydrochloride versus felodipine sustained-release for mild-to-moderate hypertension: a multi-center, randomized clinical trial. Curr Med Res Opin. 2015 Jan;31(1):171-6. doi: 10.1185/03007995.2014.960073. Epub 2014 Nov 26. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30. doi: 10.4103/0976-500X.119707. 4: Xu M, Wu Y, Wang H, Xu X, Zhao S, Zhang M, Jin H, Yan J, Wang B, Gong J, Lu X, Peng J, Dai Q. Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability. Curr Med Res Opin. 2016 Oct;32(sup2):43-52. doi: 10.3797/scipharm.1310-10. Print 2014 Apr-Jun. 6: Shetty PK, Suthar NA, Menon J, Deshpande PB, Avadhani K, Kulkarni RV, Mutalik S. Transdermal delivery of lercanidipine hydrochloride: effect of chemical enhancers and ultrasound. Curr Drug Deliv. 2013 Aug;10(4):427-34. doi: 10.1016/j.jash.2014.03.329. Epub 2014 Apr 4. doi: 10.1111/jcpt.12139. Epub 2014 Mar 17. doi: 10.1185/03007995.2014.964855. Epub 2014 Nov 26. doi: 10.1016/j.ijbiomac.2014.08.017. Epub 2014 Aug 23. doi: 10.7860/JCDR/2015/14085.6801. Epub 2015 Nov 1.